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Abstract
Adult MRL/MpJ mice have been shown to possess unique regeneration capabilities. They are able to heal an ear-punched
hole or an injured heart with normal tissue architecture and without scar formation. Here we present functional and
histological evidence for enhanced recovery following spinal cord injury (SCI) in MRL/MpJ mice. A control group (C57BL/6
mice) and MRL/MpJ mice underwent a dorsal hemisection at T9 (thoracic vertebra 9). Our data show that MRL/MpJ mice
recovered motor function significantly faster and more completely. We observed enhanced regeneration of the
corticospinal tract (CST). Furthermore, we observed a reduced astrocytic response and fewer micro-cavities at the injury site,
which appear to create a more growth-permissive environment for the injured axons. Our data suggest that the reduced
astrocytic response is in part due to a lower lesion-induced increase of cell proliferation post-SCI, and a reduced astrocytic
differentiation of the proliferating cells. Interestingly, we also found an increased number of proliferating microglia, which
could be involved in the MRL/MpJ spinal cord repair mechanisms. Finally, to evaluate the molecular basis of faster spinal
cord repair, we examined the difference in gene expression changes in MRL/MpJ and C57BL/6 mice after SCI. Our microarray
data support our histological findings and reveal a transcriptional profile associated with a more efficient spinal cord repair
in MRL/MpJ mice.
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Introduction
Injury to the mammalian spinal cord typically results in very
limited regeneration of damaged axons, causing permanent
functional deficits [1]. Central nervous system (CNS) axonal
regeneration appears to be impeded partly by myelin inhibitors [2]
and by formation of a post-lesion scar barrier [3]. However, if
axons can traverse the injury site, there is evidence that they may
re-grow into unscarred regions [4,5].
The main components of the scar are gliotic astrocytes and
microglia/macrophages [6]. Upon injury, astrocytes proliferate,
up-regulate the expression of glial fibrillary acidic protein (GFAP)
and form a dense network of glial processes at the injury site. In
addition to creating this physical barrier, astrocytic gliosis will
result in the production of a variety of cytokines, cell adhesion
and extra-cellular matrix molecules. Some of these molecules,
such as chondroitin sulfate proteoglycans (CSPG), have been
shown to inhibit axonal growth [7] and, if degraded in the glial
scar at the injury site, axonal regeneration as well as functional
recovery is promoted [8]. Similarly, suppression of glial scar
formation with a 2-Gy dose of radiation after SCI improves
functional recovery [9].
Wound healing of mammalian tissue is a long process and is
always accompanied by scarring. In general, adult mammals are
poor healers compared to lower vertebrates such as some tailed
amphibians, which can completely regenerate their spinal cord
without scar formation [10]. Among mammals, the MRL/MpJ
mouse strain has a unique capacity for wound healing and
regeneration, as shown by the closure of ear punches with normal
tissue architecture and cartilage replacement. This characteristic is
in contrast to the C57BL/6 mouse, which heals only part of the
ear punch hole and forms a scar [11]. Furthermore, the MRL/
MpJ mouse has been shown to regenerate injured heart tissue in
contrast to the C57BL/6 mouse [12]. Neither of these regenerative
repair processes is normally seen in adult mice, and the healing
response of MRL/MpJ mice is reminiscent of amphibian
regeneration with scarless healing [11,12]. More recently,
Chadwick and colleagues [13] showed that, after amputation,
MRL mouse digit tips were found to distally re-grow more quickly
and reform nails either partially or completely to a greater degree
than C57BL/6 mice. Gourevitch and colleagues [14] further
observed a blastema-like structure along apparent chondrogenesis,
consistent with a histological profile of a regenerative response to
injury.
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abilities without scarring, we investigated whether injured MRL/
MpJ spinal cord would show enhanced healing and possibly axon
regeneration without glial scar formation. To assess putative
regenerative repair in the MRL/MpJ spinal cord, we performed a
dorsal spinal cord hemisection and used C57BL/6 mice as control
animals.
Materials and Methods
Animals
The MRL/MpJ is an inbred mouse derived from the
interbreeding of 4 progenitor inbred lines: LG/J (75%), AKR/J
(12.6%), C3H/Hej (12.1%) and C57BL/B6 (0.3%) [15]. Over 20
genetic loci have been identified and their healing phenotype is a
complex multigenic and sexually dimorphic trait [16,17,18,19].
We chose C57BL/6 animals as controls because they have been
used as a control strain in all published work related to the
enhanced healing abilities of MRL/MpJ mice, including all gene
and loci identification studies [16,17,18,19,20,21]. Using the
C57BL/6 mice as a control strain thereby allows us to compare
our gene expression data to already published literature. The
intact C57BL/6 mice performed better than the MRL/MpJ
animals in the rotarod and the grid test. Therefore, the motor
recovery results were analyzed after normalizing the performance
of the injured MRL/MpJ and C57BL/6 mice to their respective
baseline levels (intact mice). It is likely that the MRL/MpJ mice
are not as agile as the C57BL/6 mice because of their higher body
weight (10-week-old female C57BL/6 weighed 20.1 g60.5 g,
MRL/MpJ weighed an average of 31.7 g60.4 g). The only
available inbred strains of mice matching the weight of MRL/MpJ
mice, the C3HeB/FeJ strain, is blind (Mouse Phenome Database,
http://www.jax.org) and therefore would not have been suitable
for behavioral testing.
Ten-week-old female MRL/MpJ and C57BL/6 mice were
purchased from the Jackson Laboratory, ME. They were housed
in groups of 5 or singly (after SCI) and had access to water and
food ad libitum at the Salk Institute animal facilities. All animal
procedures were in accordance with NIH guidelines and approved
by the Salk Institutional Animal Care and Use Committee.
Intraperitoneal injections of ketamine (100 mg/kg) and xylazine
(10 mg/kg) were used as anesthesia for all surgical procedures and
before perfusion.
SCI and post-operative care
Under appropriate aseptic techniques, 10-week-old female mice
(22 MRL/MpJ and 22 C57BL/6) received a partial dorsal
laminectomy at a single thoracic vertebral segment (T9). The
spinal cord was exposed and Lidocaine (2%, 10 ml, Bimeda,
Riverside, MO) was applied to the dura for 1 minute to
anesthetize the region to be transected. The dorsal half of the
spinal cord was cut 0.5 mm deep with a pair of microscissors to
sever the main parts of the CST, including the dorsal lateral
component of the CST (the diameter of the spinal cord at T9 was
not significantly different between the two strains, allowing injuries
of equal sizes for both strains). The overlaying muscle layers were
sutured and the skin was stapled closed. Postoperatively, all
animals were placed singly in a cage on warming pads and were
provided with moist food pellets on the bottom of the cage.
Temperature and respiration were monitored until animals were
fully awake. Then cages were placed back on the housing system
rack. Bladders were manually expressed twice a day until normal
voiding reflexes returned. An antibiotic (enrofloxacin, 2.27 mg/kg,
Baytril, Bayer, KS) was given once daily for 6 days. Animals were
transcardially perfused with saline, followed by 4% paraformal-
dehyde at different time points post-SCI.
Behavioral analyses
Intact MRL/MpJ and C57BL/6 mice (n=10 in each group)
were used to establish the baseline performance of each strain in
the rotarod, grid and footprint test (baseline group). Also, injured
groups of 10 MRL/MpJ and 10 C57BL/6 mice were tested 4 days
before the injury and up to 88 days after the injury.
Rotarod test. The Rotamex 4/9 (Columbus Instrument,
OH) was used to evaluate fore-and hindlimb motor coordination
and balance. Each mouse was placed on the slowly moving
rotarod (5 rpm) and the trial was started when the animal found its
balance. The rotarod accelerated from 5 rpm to a maximum of
70 rpm within 3 minutes. The latency to fall off the rotarod was
recorded. Mice underwent 3 consecutive trails. The mean latency
for 3 trails was used for statistical analysis.
Grid test. This test evaluated the ability of the mice to
navigate over a wire mesh grid (2.562.5 cm grid spaces,
28635 cm total area). Each mouse was videotaped while on the
grid until it achieved a total of 20 steps. A foot-fault was scored
each time the animal misplaced its hindlimb to protrude entirely
or partially through the grid.
Bladder function. The bladder of each injured animal was
voided twice daily until it recovered autonomic bladder function.
The amount of urine voided (or the level of ‘‘bladder fullness’’) was
estimated and ranked from 3 to 0: 3=dysfunctional; full bladder,
medium to high pressure needed to manually express it and a large
amount of urine expressed, 2=medium amount of urine expressed
after medium pressure, 1=small amount of urine expressed after
slight pressure, and 0=empty bladder and no urine expressed.
CST tracing
Six MRL/MpJ and 6 C57BL/6 received bilateral CST tracing
at 40 days post-injury (dpi), 10 MRL/MpJ and 10 C57BL/6 at
95 dpi, and 2 intact MRL/MpJ and 2 intact C57BL/6 also
received bilateral CST tracing. A hole was drilled on each side of
the skull overlying the sensorimotor cortex. The anterograde
neuronal tracer biotin dextran amine (BDA) (10% BDA in 0.01 M
phosphate buffer, pH 7.4; Molecular Probes, Eugene, OR) was
injected (2 ml) at 4 injection sites into the sensorimotor area
(anterior-posterior coordinates from bregma in mm: 1.0/1.5, 0.5/
1.5, 20.5/1.5, 21.0/1.5, at a depth of 0.5 mm) using a Hamilton
syringe. Two weeks after BDA injection, the animals were
perfused and tissue was collected for histology.
BrdU injections
Bromodeoxyuridine (BrdU; Sigma) was dissolved in 0.9% NaCl
and filtered at 0.2 mm. To label dividing cells in intact mice, 12
animals received a daily intraperitoneal injection for 6 consecutive
days at a dose of 50 mg/kg body weight (10 mg/ml BrdU). Six
mice were sacrificed 1 day and 6 mice were sacrificed 4 weeks after
the last injection to assess rate of proliferation, differentiation and
survival of mitotic cells. SCI mice received the first injection
2 hours after the injury. Six lesioned mice received a single
injection 2 hours after injury and were sacrificed 1 day later.
Twenty injured mice received one injection per day for 6 days. Of
these, 10 animals were sacrificed at 54 dpi and 10 were sacrificed
at 109 dpi.
Tissue processing
Spinal cords were cut into 7-mm segments and embedded in
cryomolds (Fisher Scientific, Pittsburgh, PA) with O.C.T.
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cord segments were stored at 280uC until processed further.
Spinal cords were sectioned sagittally on a cryostat at 20 mm
thickness and stored on slides at 220uC.
CST detection and analysis
The spinal cord sections were incubated with an avidin–biotin–
peroxidase complex (ABC Elite, Vector Laboratories, Burlingame,
CA), and the BDA tracer was visualized by a nickel-enhanced
diaminobenzidine (DAB) reaction [22]. BDA-labeled fibers were
quantified at 0.5 mm and 2 mm caudal and at 5 mm rostral to the
lesion site. To account for inter-individual tracing variability,
numbers were normalized to the amount of fibers 5 mm rostral to
the lesion site, where the CST was intact, and are presented as
percentages [8].
BrdU immunohistochemistry and quantification
For the stereological quantification of BrdU-labeled cells,
cryostat sections were stained with rat anti-BrdU primary antibody
(1:100; Accurate Chemicals) for DAB immunohistochemistry.
BrdU-labeled cells in intact mice were quantified as described
before [23]. To obtain the number of BrdU-labeled cells per mm
3
in injured spinal cords, labeled cells were counted at the injury
epicenter, every 60 mm through the entire width of the spinal cord.
For each sagittal section, the area surrounding the injury epicenter
(5 mm surrounding the injury epicenter) was traced and recorded
using a mechanical stage attached to an Olympus BH2
microscope, a Dage MTI CCD-300TIFG Video camera (Michi-
gane City, IN) and the StereoInvestigator software (MicroBright-
field, Colchester, VT). The number of labeled cells within each
traced area was recorded.
Multiple marker immunofluorescence and quantification
Sections were processed for multiple markers to determine the
phenotype of BrdU-labeled cells. Primary antibodies detecting
immature and mature astrocytes (S-100b polypeptide), mature
astrocytes (GFAP), oligodendrocyte progenitors (NG2), microglia
(OX-42), and immature (TUJ1) and mature neurons [neuronal
nuclear antigen clone A60 (NeuN)] were used. Cryostat sections
were pretreated for BrdU detection as described previously [23].
Three compatible primary antibodies were incubated on the
sections for 2 days at 4uC in TBS +0.1% Triton X-100 +5%
donkey serum. Primary antibodies were used at the following
concentrations: rat anti-BrdU (1:100; Accurate Chemicals), rabbit
anti-S-100b (1:10,000; SWant, Bellinzona, Switzerland), mouse
anti-NeuN (1:10; clone A60; Dr. R. Mullin, Salt Lake City, UT),
rabbit anti-GFAP (1:1000; Dako, Carpinteria, CA), rabbit anti-
NG2 (1:500; Chemicon, Temecula, CA) and mouse anti-OX-42
(1:200; Serotec, UK). Sections were rinsed twice in 0.1 M TBS,
pH 7.5, and blocked in 0.1 M TBS +0.1% Triton X-100 for
15 min before application of secondary antibodies. The following
secondary antibodies were applied in 0.1 M TBS and 0.1% Triton
X-100, each at a concentration of 1:250 for 2 hr in the dark:
donkey anti-rat IgG conjugated to FITC (1:250; Jackson
ImmunoResearch, West Grove, PA), donkey anti-mouse conju-
gated to Cy2 or Cy5 (1:250; Jackson ImmunoResearch), and
donkey anti-rabbit conjugated to Cy2 or Cy5 (1:250; Jackson
ImmunoResearch). Incubation with secondary antibodies was
followed by three rinses (15 min) in TBS. Slides were then
immediately coverslipped using polyvinyl alcohol-1,4 diazabicy-
clo[2.2.2]octane and kept in the dark at 4uC until analysis.
Multiple label immunofluorescent images were collected and
quantified using confocal microscopy (Bio-Rad MRC 1000,
Hercules, CA). Single confocal plane images of BrdU or
phenotype markers (see above) were collected and combined to
assess co-localization. A cell was scored for double-staining when a
well-defined BrdU-labeled nucleus was associated with an
immunopositive (e.g., GFAP, S100b etc.) cell body. The entire
cell was followed through the z-axis, and only cells with a well-
circumscribed, immunopositive soma were considered positive for
a particular phenotype. A total of 100 BrdU cells were randomly
counted at the injury epicenter.
TdT-mediated dUTP nick end labelling (TUNEL) assay
Apoptosis was examined by TUNEL assay, using a commer-
cially available kit (Oncor, Apoptag). The modified protocol
developed by Whiteside et al. was followed to simultaneously
counterstain with Hoechst 33342 [24]. TUNEL positive cells were
only counted as apoptotic cells if the nucleus had fragmented into
several membrane-bounded, highly condensed bodies and if it
exhibited shrinkage of both cytoplasm and nucleus, creating
pericellular space. Any artifacts of TUNEL labeling, i.e., non-
nuclear material, was disregarded.
Detection and quantification of micro-cavities
The sections were counterstained with GFAP antibody (rabbit
anti-GFAP, 1:1000; Dako). To obtain the number of micro-
cavities per mm
3, micro-cavities were counted at the injury
epicenter, every 60 mm through the entire width of the spinal cord.
For each section the area surrounding the injury epicenter was
traced and recorded as described above. The number of micro-
cavities within the traced area was recorded.
Statistical evaluation
All the behavioral data and quantification of traced CST fibers
were analyzed using a two-factor ANOVA. Post hoc analysis was
carried out using Bonferroni-corrected individual comparisons
(Microsoft Excel and XLSTAT; Addinsoft, NY). Statistical
evaluation of bladder recovery was assessed by a non-parametric
Mann Whitney test. Statistical evaluation of BrdU cell counts and
micro-cavity quantification was performed using a Student’s t-test.
In all analyses, a P-value of less than 0.05 was chosen as
significance threshold. All data are presented as the mean 6
standard error of the mean (SEM).
Experimental design for the microarray gene expression
analysis
For MRL/MpJ and C57BL/6 mice, three groups were
examined at 4 dpi: intact control, laminectomy control and
hemisection at T9. For each condition, 3 mice were sacrificed and
a 1-cm spinal cord segment containing the injury epicenter was
collected.
RNA extraction and microarray procedures
The procedure was performed as described in detail before [25].
Total RNA was extracted from each sample individually using
TRIzol reagent (Invitrogen, Carlsbad, CA). First-strand cDNA
was generated by using a T7-linked-(dT)24 primer. After second-
strand synthesis, the double-stranded cDNA was used for in vitro
transcription using the ENZO BioArray High-Yield RNA
transcript labeling kit (ENZO, Farmingdale, NY). The labeled
cRNA was purified and fragmented. Each fragmented, biotin-
labeled cRNA sample (20 mg) was hybridized to an Affymetrix
mouse 430A chip. After scanning, array images were assessed by
eye to confirm scanner alignment and the absence of significant
bubbles or scratches. Chips had to meet the following criteria to be
included in the data analysis: the number of probe pairs called
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bacterial controls had to be called present, background had to be
,200, the number of outliers had to be ,500, and the 3V/5V
ratio of GAPDH and actin had to be ,2.
Microarray data analysis and quantitative PCR validation
The chips were analyzed using two different complementary
analytical tools. Data were preprocessed (*.dat files to *.cel files)
using Affymetrix Microarray Analysis Suite (MAS) 4.0. Data were
subsequently analyzed using the dChip 1.3 PM-MM [26] and the
Drop Method [27]. dChip approximates expression values by
modeling the whole body of chip data to an ideal system, and
Drop determines the significance of change between the triplicate
groups statistically with minimal assumptions.
To detect up- or down-regulated genes following SCI,
Hemisection chips were compared to Laminectomy control chips
for both strains of mice. Each group had 3 chips, so each
comparison had a 363 design, with a possibility of 9 pairwise
comparisons for each group. To obtain a list of genes that were
differentially expressed after SCI in MRL/MpJ animals, but not
significantly changed in C57BL/6 mice, we compared the gene
lists of MRL/MpJ and C57BL/6 mice after imposing very strict
criteria (dChip fold change.1.2 AND Drop method confi-
dence=95%) for the MRL/MpJ chips and very loose criteria
(dChip fold change.1.2 OR Drop method confidence=50%) for
the C57BL/6 chips. To detect differentially expressed genes
between the 2 uninjured strains, Intact control chips from MRL/
MpJ were compared to Intact control chips from C57BL/6. For
statistical significance we imposed dChip fold change.1.2 and
Drop method confidence=95%.
Expression changes of genes of interest were verified by
quantitative RT-PCR (Q-PCR). cDNA was prepared from RNA
samples used for GeneChip analysis, and reverse transcription was
performed using Superscript First-strand cDNA Synthesis System
(Invitrogen). Primer Express v1.5 software was used to design
oligonucleotide primers (Applied Biosystems, Foster City, CA) (see
methods Table S1 for sequences of primers), which were
constructed by Sigma-Aldrich. Q-PCR was performed with
3.33 ng of cDNA, SYBR Green Master Mix (Applied Biosystems),
and 0.2 mM of each primer in a 25-ml reaction. All reactions were
performed in triplicate using an ABI Prism 7700 Sequence
Detection System (Applied Biosystems). Data analysis was
performed according to the protocol provided by Applied
Biosystems using Sequence Detector Systems v1.7 software. Intact
spinal cord cDNA was used to create standard curves for both
strains. Expression of each gene was calculated based on the
standard curve for a given primer set. The relative amount of
calculated message was normalized to the level of a control gene
(18s rRNA). The Q-PCR results are summarized in table 1
Results
Enhanced functional recovery of MRL/MpJ mice after SCI
The locomotor performance of injured mice was assessed at
several time points up to 88 dpi. Due to the disparity in
performance between intact MRL/MpJ and C57BL/6 mice, a
Table 1. Fold changes for the 10 most up- and down-regulated genes in MRL/MpJ compare to C57BL/6 mice after spinal cord
hemisection.
Up-regulated Genes
MRL/MpJ Fold
Change
C57Bl/6 Fold
Change Down-regulated Genes
MRL/MpJ Fold
Change
C57Bl/6 Fold
Change
interferon activated gene
202B [GeneID: 26388]
35.66 [48.80] 1.00 [0.98] Mus musculus adult male olfactory brain
cDNA, RIKEN full-length enriched library,
clone:6430537M22 product:unknown EST,
full insert sequence.
24.43 21.82
allograft inflammatory factor
1 [GeneID: 11629]
23.83 [32.15] 3.14 [2.32] potassium voltage-gated channel,
shaker-related subfamily, beta member
1 [GeneID: 16497]
23.75 [24.52] 21.61 [22.96]
histidine ammonia lyase
[GeneID: 15109]
18.4 [15.34] 2.09 [3.43] calcitonin-related polypeptide, beta
[GeneID: 116903]
23.55 [24.82] 21.50 [21.03]
Mus musculus, clone
MGC:28142 IMAGE:3982042,
mRNA, complete cds
7.88 2.70 vesicle-associated membrane
protein 1 [GeneID: 22317]
23.41 [22.98] 21.34 [20.63]
cDNA sequence BC032204
[GeneID: 108101]
5.75 1.85 sulfotransferase family 4A, member
1 [GeneID: 29859]
23.36 [24.23] 21.63 [21.06]
apolipoprotein B editing
complex 1[GeneID: 11810]
4.68 [6.98] 1.68 [1.85] regulator of G-protein signaling 4
[GeneID: 19736]
23.16 [22.98] 21.35 [20.85]
cDNA sequence BC032204
[GeneID: 108101]
4.45 1.81 Parvalbumin [GeneID: 19293] 23.10 [24.50] 21.32 [21.28]
Rho, GDP dissociation inhibitor
(GDI) beta [GeneID: 11857]
4.44 [3.96] 1.85 [1.78] creatine kinase, mitochondrial 1,
ubiquitous [GeneID: 12716]
23.02 [22.20] 21.87 [21.00]
beta-glucuronidase
[GeneID: 110006]
4.27 [3.98] 1.63 [1.86] cartilage acidic protein 1
[GeneID: 72832]
23.00 [25.02] 21.30 [21.32]
cysteine rich protein 61
[GeneID: 16007]
4.18 [6.40] 1.86 [2.59] solute carrier family 17 (sodium-
dependent inorganic phosphate
cotransporter), member 6
[GeneID: 140919]
22.94 [21.98] 21.23 [20.75]
The complete data set is available at http://genechip.salk.edu/rawdata/Thuret_MRL.zip.
Expression changes of genes of interest were also verified by quantitative RT-PCR (Q-PCR). When applicable, the Q-PCR fold changes are presented in brackets [ ].
doi:10.1371/journal.pone.0030904.t001
Recovery from SCI in MRL/MpJ Mice
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e30904control group of intact, age-matched MRL/MpJ and C57BL/6
animals underwent the same behavioral tests as the injured mice to
establish the baseline performance for both mice strains.
The rotarod test evaluates fore- and hindlimb motor coordina-
tion and balance. Intact mice of both strains improved and
reached a plateau at 18 days, showing the same performance up to
88 days (Fig. 1a). However, C57BL/6 mice performed better from
the start (72.02 s64.73) and were able to stay longer on the
rotarod (at 88 days, 91.1 s64.5) than the MRL/MpJ (at start:
45.56 s65.03; at 88 days, 65.1 s65.4; Fig.1a). In both mouse
strains, the rotarod perfomance decreased after SCI (MRL/MpJ,
213.0 s64.0 and C57BL/6, 219.0 s63.5). Interestingly, the
injured MRL/MpJ mice reached their baseline level by the end of
88 days of testing, whereas the performance of the injured
C57BL/6 animals was still reduced (23.5 s63.9 below their
baseline performance at 88 days; Fig. 1a). To eliminate the strain
differences in rotarod performance from the recovery curve after
SCI, the performance of the injured MRL/MpJ and C57BL/6
mice was normalized to their respective baseline levels (Fig. 1b).
There was no difference in the normalized rotarod performance of
MRL/MpJ and C57BL/6 mice at 4 days after injury, indicating
that both strains were affected equally by the SCI. Interestingly,
MRL/MpJ mice recovered rotarod performance over time
whereas C57BL/6 did not recover over the 88 days of testing
[repeated measures ANOVA: effect of group (F1, 18=149.2,
P,0.0001), time (F13, 234=5.5, P,0.0001), interaction group6
time (F13, 234=3.1, P,0.0005)]. Individual comparisons (Bonfer-
roni post-hoc) between groups indicated that injured MRL/MpJ
performed significantly better than injured C57BL/6 at 12, 18, 53,
60, 67, 74 and 88 dpi (P,0.002).
The grid test was used to assess deficits in descending fine motor
control after SCI. Intact animals of both mouse strains improved
their ability to cross the grid with fewer foot-faults over time
(Fig. 1c). However, intact MRL/MpJ animals made significantly
more foot-faults through the entire training period (18 days,
2.460.5 foot-faults; p=0.0025) than C57BL/6 (18 days, 0.860.15
foot-faults). Following SCI, animals from both strains made more
foot-faults when crossing the grid: MRL/MpJ 9.562.7 and
C57BL/6 mice 3.561.6 additional foot-faults. The injured
MRL/MpJ animals reached their baseline level by 12 dpi,
whereas the injured C57BL/6 never recovered back to their
baseline level within the testing period of 18 days (Fig. 1c). To
account for differences in baseline performance, the number of
foot-faults of the injured mice was expressed as a ratio of the
baseline (Fig. 1d). Again, we did not find significant differences in
the normalized performance on the grid walk of MRL/MpJ and
C57BL/6 4 days after the injury, indicating that both strains were
impaired similarly by the SCI. MRL/MpJ mice showed a better
performance than C57BL/6 on the grid at 12 and 18 days
[repeated measures ANOVA: effect of group (F1, 18=10.4,
P,0.002), time (F3, 54=3.7, P,0.01), interaction group6time
(F3, 54=2.0, P.0.1); in individual comparisons (Bonferroni post-
Figure 1. Enhanced functional recovery after SCI in MRL/MpJ mice. a, The latency to fall off the rotarod is depicted as a function of time for
intact (baseline) and injured MRL/MpJ and C57BL/6 mice. In both strains intact mice improved their performance over the course of the 88 days of
training, but the C57BL/6 performed better at all time points tested. The injured MRL/MpJ reached their baseline level by the end of the 88 days of
testing, whereas the injured C57BL/6 did not. b, Rotarod performance of injured mice is expressed as a ratio of baseline performance. Injured MRL/
MpJ performed significantly better than injured C57BL/6 at 12, 18, 53, 60, 67, 74 and 88 dpi (*P,0.002). Injured MRL/MpJ significantly improved
between 4 dpi and 88 dpi (#P,0.002), whereas injured C57BL/6 did not improve during that period. c, The number of foot-faults made during grid
walking is reported as a function of time for intact (baseline) and injured MRL/MpJ and C57BL/6 mice. Both intact strains improved their ability to
cross the grid with fewer foot-faults, but intact MRL/MpJ made more foot-faults throughout the entire training period. The injured MRL/MpJ reached
their baseline level already by 12 dpi, whereas the injured C57BL/6 still had not reached their baseline level by the end of the testing period at 18 dpi.
d, Grid walking performance of injured mice is expressed as a ratio to baseline performance. Injured MRL/MpJ performed significantly better than
injured C57BL/6 at 12 and 18 dpi (p,0.05). Injured MRL/MpJ had significantly improved between 4 dpi and 12 dpi, 18 dpi (p,0.05), whereas injured
C57BL/6 did not improve during that period. e, Estimation of bladder fullness is reported as a function of time after SCI in MRL/MpJ and C57BL/6
mice. All MRL/MpJ mice recovered autonomic bladder function by 3 dpi, whereas in C57BL/6 mice, autonomic bladder function did not returned until
6 dpi (Mann Whitney test, p-value=0.028). Data present mean 6 SEM. * denotes significant difference between MRL/MpJ and C57BL/6 and #
denotes significant differences in MRL/MpJ performance between time points (P value: two-way ANOVA, Bonferroni post-hoc analysis).
doi:10.1371/journal.pone.0030904.g001
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injured C57BL/6 at 12 and 18 dpi, P,0.05].
The gait of the lesioned mice was evaluated by analyzing
footprint patterns. When assessing base of support and stride
length, we found a trend for the injured MRL/MpJ mice to
recover faster than the injured C57BL/6 animals, but the
differences were not statistically significant (data not shown).
The bladders of the injured animals were manually expressed
twice daily until the mice had recovered autonomic bladder
function. At 6 hours post-injury (0 dpi), none of the injured
animals showed autonomic bladder function. All MRL/MpJ mice
recovered autonomic bladder function by 3 dpi, whereas in
C57BL/6 mice, autonomic bladder function did not return until
6 dpi [Mann Whitney test of group difference in Area Under
Curve summary statistic of mouse bladder function recovery;
p-value=0.028)].
Enhanced regeneration of CST axons in MRL/MpJ mice
after SCI
To show that the CST was completely transected by our lesion
approach (a 0.5 mm dorsal hemisection), intact MRL/MpJ and
intact C57BL6 mice were injected with BDA. Two weeks later
these mice underwent a dorsal hemisection and the CST was
assessed at 4 dpi (i.e., 18 days after tracing). In both mouse
strains the dorsal CST was BDA-labeled and fully transected.
Axons were observed rostral as well as caudal to the injury site,
but there were no BDA-labeled fibers in the injury epicenter
(Fig. 2 a, b).
To analyze the regeneration of the CST after SCI, injured
animals were injected with BDA at 40 or 95 dpi. Irrespective of
the time point of BDA tracing, we found that C57BL/6 CST
axons had retracted from the lesion site and we observed very few
or no fibers caudal to the lesion (Fig. 2c, e, g). In contrast, MRL/
MpJ CST fibers were present at the lesion site as well as caudal to
the injury. Moreover, in some cases, CST axons crossed through
the lesion site (Fig. 2d, f, h). At both time points, MRL/MpJ mice
displayed significantly more fibers at and caudal to the lesion site
compared to C57BL/6 mice [Fig. 2i, j; two-way ANOVA revealed
significant effect of group (54 dpi: F1, 10=6.8, P,0.05; 109 dpi:
F1, 18=11.2, P,0.005)]. Individual comparisons (Bonferroni post-
hoc) between groups indicated that injured MRL/MpJ had
significantly more regenerating fibers at 0.5 mm rostral to the
lesion site (P,0.02): 54 dpi: 19.369.9% for MRL/MpJ versus
1.361.3% for C57BL/6; 109 dpi: 19.569.2% for MRL/MpJ
versus 3.261.5% for C57BL/6.
In both mouse strains, no significant difference in fiber
quantification was found between 54 dpi and 109 dpi, demon-
strating that the regenerated fibers were stable and did not retract.
Reduced astrocytic response and micro-cavity formation
in MRL/MpJ mice after SCI
At 54 dpi the dorsal surface of the injury site in the C57BL/6
mice was convex, bulging and filled with densely packed GFAP-
positive astrocytes. Numerous GFAP-positive astrocytes were
delineating the injury site forming a glial scar (Fig. 3a, c). In
MRL/MpJ mice, the dorsal surface of the injury site was concave
and contained GFAP-negative cells surrounded by a few GFAP-
positive astrocytes. The incision site itself was no longer visible in
MRL/MpJ spinal cord (Fig. 3b, d). Furthermore, the lesion
epicenter of C57BL/6 mice contained 10 times more micro-cysts
than the lesion site of MRL/MpJ mice (211.9623.3 micro-
cavities/mm
3 vs. 26.162.7 micro-cavities/mm
3; Student’s t-test,
p,0.002; Fig. 3.e, f, g).
At 109 dpi the tissue looked similar to 54 dpi in C57BL/6 mice:
the injury site in the C57BL/6 mice was still visible, filled with
GFAP-positive astrocytes and micro-cavities (Fig. 3h). In MRL/
MpJ mice, the dorsal surface of the injury site was flat and fewer
GFAP-positive astrocytes were present (Fig. 3i) when compared to
the C57BL/6 injury site. The lesion site could be located because
of the higher cell division at the injury site compared to the
surrounding spinal cord tissue.
Cell proliferation is different in the intact and injured
spinal cord in MRL/MpJ mice
Previous studies have identified progenitor cells throughout the
intact and injured rodent spinal cord [23,28,29,30]. Therefore, we
examined whether differences between C57BL/6 and MRL/MpJ
endogenous spinal cord progenitor cell proliferation could account
for the enhanced healing properties of MRL/MpJ mice.
Quantification of BrdU-positive cells in intact spinal cord 1 day
after six days of BrdU application revealed a higher level of
proliferation in MRL/MpJ mice (p,0.05; Fig. 4b,c). Survival of
the progeny of dividing progenitor cells was assessed by evaluating
BrdU-positive cells 4 weeks after the last BrdU injection and
comparing the number of labeled cells with the number obtained
at 1 day after the last injection. The total number of surviving
BrdU-positive cells after 4 weeks in MRL/MpJ spinal cord was not
significantly different from C57BL/6 mice (p.0.05; Fig. 4c). The
cell fate of the BrdU-positive cells 4 weeks post-injection was also
assessed in the intact spinal cord. As reported previously for the rat
intact spinal cord [23], there was no sign of ongoing neurogenesis
detected in MRL/MpJ or C57BL/6 intact spinal cords. In both
strains, the majority of the BrdU-positive cells was immature glia
(co-labeled with NG2) or mature astrocytes (co-labeled with
S100b/GFAP). No significant differences were detected between
MRL/MpJ and C57BL/6 (data not shown).
As described previously [28,29,30], a substantial increase in
cellular proliferation occurs after SCI in and around the injury site
(Fig. 4d–f). We injected BrdU 2 h after SCI and once daily for
6 dpi. When compared to intact mice, the number of proliferating
cells at the site of injury at 1 dpi was 23.5-fold higher for C57BL/6
mice and only 9.6 times higher for MRL/MpJ mice (p,0.05),
showing that MRL/MpJ injured cord contained 1.5 times fewer
BrdU-labeled nuclei than C57BL/6 lesioned cord. The number of
BrdU-labeled nuclei in MRL/MpJ mice was still 1.5 times lower at
54 dpi (Fig. 4 e, f), whereas no significant difference was found at
109 dpi.
Apoptotic cells were detected at 1 dpi using TUNEL labeling
[31]. Numerous TUNEL-positive cells exhibiting typical frag-
mented and condensed nucleus were detected at the injury
epicenter in both mouse strains (MRL/MpJ: 32926569 apoptotic
cells/mm
3; C57BL/6 36456631 apoptotic cells/mm
3). Similarly,
Fluorojade staining specifically detecting neuronal cell death [32]
revealed no differences between MRL/MpJ (24996101 Fluor-
ojade-positive cells/mm
3) and C57BL/6 mice (25906348 degen-
erating neurons/mm
3) at 1 dpi at the injury site.
Reduced astrocytic and increased microglial
differentiation of proliferating cells in MRL/MpJ injured
spinal cord
Since it has been suggested that the astrogliotic scar is in part
produced by proliferating precursor cells differentiating into
astrocytes post-injury [29,33,34,35], the cell fate of the dividing
cells after SCI was examined in both strains.
In intact mice, differentiation of the surviving BrdU-positive
cells was examined in the spinal cord 4 weeks after the last BrdU
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double labeling for BrdU with lineage-specific markers (neuronal
markers NeuN and TUJ1, glial progenitor marker NG2, astrocyte
markers GFAP and S100b,microglia marker OX-42). Nosignificant
differences were found between MRL/MpJ and C57BL/6 mice
(data not shown). In accordance with previous publications [23,28],
no evidence of neurogenesis was found. Many proliferating cells
were oligodendroglial progenitor cells (.40%), approximately 5%
were astrocytes and fewer than 1% were microglia.
We then assessed the phenotype of BrdU-positive cells in
injured mice. At 54 dpi, no neurogenesis occurred in either of the
strains and most of the surviving proliferating cells exhibited a glial
phenotype (Fig. 5). The proportions of BrdU-positive cells co-
labeled with NG2 (9.762.1% vs 4.762.0%), S100b (4.062.1% vs
2.961.4%) and OX-42 (2.061.4% vs 1.661.4%) in C57BL/6
versus MRL/MpJ mice were not significantly different (Fig. 5s).
Nevertheless, BrdU+/GFAP+ cells were significantly higher in
C57BL/6 mice (22.560.5%) than in MRL/MpJ animals
(16.160.8%; p,0.05; Fig. 5s). When we assessed double-labeled
cells (absolute numbers) per volume, we found that C57BL/6 mice
had almost 3 times more NG2+/BrdU+ cells (Fig. 5g–l) and 2
times more GFAP+/BrdU+ cells (Fig. 5a–f) than MRL/MpJ mice
Figure 2. Enhanced regeneration of corticospinal tract (CST) axons in MRL/MpJ mice after SCI. a, b, Sagittal sections of BDA-labeled CST
axons in C57BL/6 (a) and MRL/MpJ (b) mice. Two weeks after tracing, dorsal hemisections were performed. The CST was analyzed at 4 dpi (=18 days
after tracing). In both mouse strains, axons are visible rostral and caudal from the injury site. No BDA-labeled fibers were found at the injury site,
confirming that the CST was completely transected. c, d, Sagittal sections of BDA-labeled CST axons in injured C57BL/6 (c) and MRL/MpJ (d) mice at
54 dpi. Here, BDA tracing was performed right after SCI. C57BL/6 CST axons retracted from the lesion (arrowhead in c). In contrast, some MRL/MpJ
CST fibers crossed through the lesion site (arrowhead in (d)). e, f, Montage of sagittal sections of BDA-labeled CST axons in C57BL/6 (e) and MRL/MpJ
(f) mice at 109 dpi. Higher magnifications are shown in g (from boxed area in e) and h (from boxed area in f). We found no BDA-positive fibers below
the injury site in C57BL/6 spinal cord (e, g), in contrast to MRL/MpJ mice (f, h). i, j, Data represent percentage of fibers and are reported as a function
of the distance from the lesion at 54 dpi (i) and 109 dpi (j). MRL/MpJ mice exhibited significantly more regenerating axons at 0.5 mm caudal from the
lesion site. Rostral end of the spinal cord is to the left. The arrows point at the injury site. Asterisks denote significant differences between MRL/MpJ
and C57BL/6, P,0.02 (two-way ANOVA, Bonferroni Post-hoc). Scale bar, 250 mm( a–d); 300 mm( e, f); 100 mm( g, h).
doi:10.1371/journal.pone.0030904.g002
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the number of OX-42+/BrdU+ cells. At 109 dpi, the phenotype of
BrdU-labeled cells was similar to 54 dpi with C57BL/6 mice,
showing still more GFAP+/BrdU+ cells than MRL/MpJ mice
(1167.86172.3 vs 660.96151.5; p,0.05; Fig. 5t, v). But
interestingly, at 109 dpi, OX-42+/BrdU+ cells were absent in
C57/BL6 mice, whereas they represented 2.760.9% of the MRL/
MpJ BrdU-labeled cells (p,0.05; Fig. 5n–r, t, v).
Gene expression profiling of the MRL/MpJ and C57BL/6
injured spinal cord
To assess the molecular events occurring in the MRL/MpJ
spinal cord after injury and to reveal putative candidate genes
responsible for the enhanced spinal cord repair, we used
microarray technology. To exclude as many genes as possible
that are changed by SCI in general, and to find genes that are
strictly differentially regulated in MRL/MpJ mice, we used
different criteria when analyzing the gene chips. We used ‘‘loose’’
criteria (dChip1.3 fold change.1.2 OR Drop method confi-
dence=50%) to reveal differentially expressed genes in C57BL/6
spinal cord 4 days after dorsal hemisection and found 1538 genes.
We applied ‘‘strict’’ criteria (dChip1.3 fold change.1.2 AND
Drop method confidence=95%) to find genes differentially
expressed in MRL/MpJ spinal cord 4 days after dorsal
hemisection and found 745 genes. Of these genes, 272 are
exclusively regulated in MRL/MpJ injured spinal cord (Fig. 6a;
complete data set available at http://genechip.salk.edu/rawdata/
Thuret_MRL.zip). We also compared gene expression in the
intact spinal cord of MRL/MpJ and C57BL/6 mice using the
‘‘strict’’ criteria and found 54 genes to be differentially expressed.
Figure 3. Reduced astrocytic response and micro-cavity formation in MRL/MpJ mice after SCI. a, b, Sagittal sections of the lesion
epicenter at 54 dpi labeled with GFAP (red) and counterstained with DAPI (blue) in C57BL/6 (a) and MRL/MpJ (b) mice. Higher magnifications are
shown in c (from boxed area in a) and d (from boxed area in b). The dorsal surface of the injury site in the C57BL/6 mice bulged out and was filled
with GFAP-positive astrocytes. In white and gray matter, numerous GFAP-positive astrocytes delineated the incision site (a, c). In MRL/MpJ mice, the
dorsal surface of the injury site was concave and contained GFAP-negative cells surrounded by a few GFAP-positive astrocytes. The incision site was
not visible any more (b, d). e, f, Sagittal sections of the lesion epicenter at 54 dpi stained for GFAP in C57BL/6 (e) and MRL/MpJ (f) mice. Numerous
micro-cavities (arrowheads) are present at the injury site (arrows) in C57BL/6 mice (e) compared to none or few in MRL/MpJ mice (f). g, Bars represent
the number of micro-cavities per cm
3 at the injury epicenter at 54 dpi. C57BL/6 injured spinal cord developed significantly more micro-cavities than
MRL/MpJ cord. h, i, Sagittal sections of the lesion epicenter at 109 dpi labeled with GFAP (red) and BrdU (green) in C57BL/6 (h) and MRL/MpJ (i) mice.
The injury site of the C57BL/6 mice was filled with GFAP-positive astrocytes and micro-cavities were present (h). The injury site in the MRL/MpJ mice
was not visible any more and could only be located by the presence of BrdU+ cells. The dorsal surface of the injury site was flat and few GFAP-positive
astrocytes were present. (i). Asterisks denote significant difference between MRL/MpJ and C57BL/6, P,0.002 (Student’s t-test). Scale bar, 250 mm
(a, b, h, i); 140 mm( c, d); 125 mm( e, f).
doi:10.1371/journal.pone.0030904.g003
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differentially expressed in MRL/MpJ injured spinal cord exclu-
sively.
We focused our interest on the genes that were exclusively
differentially expressed in MRL/MpJ injured spinal cord and
classified the 103 upregulated genes (Fig. 6b) and the 169
downregulated genes by biological function (Fig. 6c). More than
a quarter of these genes are to date Expressed Sequence Tags
(ESTs) or have an unknown function. Following SCI, MRL/MpJ
mice appear to upregulate mainly genes implicated in repair
mechanisms: 10% of the upregulated genes are involved in
cytoskeleton reorganization, 16% take part in protein and
ribozome biosynthesis and 24% participate in cell cycle, DNA
replication, lipid metabolism, angiogenesis, glycolysis or cell
adhesion. Genes involved in inflammatory processes (6%) are also
upregulated upon SCI in MRL/MpJ mice. Among the 169 down-
regulated genes, 24% are involved in cell proliferation and
differentiation, 12% in cation/ion transport and 12% take part in
the signal transduction cascade. Genes participating in the protein
ubiquitination process are also downregulated (10%), suggesting a
diminished cellular degradation upon SCI in MRL/MpJ mice.
Table 1 shows the 10 most up- and down-regulated genes in
MRL/MpJ injured spinal cord of which expression levels have
also been verified by Q-PCR. In particular, the interferon
activated gene 202B (Ifi202b) -encoding p202b [36]- is increased
35.66 fold in the injured MRL/MpJ spinal cord and is unchanged
in C57BL/6 (Table 1). The second highest fold change difference
(x7.59) is the allograft inflammatory factor 1 gene (Aif1). This gene
is an interferon (IFN)-gamma-inducible Ca2+-binding EF-hand
protein.
The identification of candidate genes that complement our
histological findings reveals potential molecular mechanisms
associated with the enhanced spinal cord healing ability of
MRL/MpJ mice.
Discussion
The aim of this work was to assess whether MRL/MpJ mice
show enhanced spinal cord repair upon injury. We performed a
dorsal spinal cord hemisection and used the C57BL/6 mouse as a
control strain. We show in this study that MRL/MpJ mice recover
faster than C57BL/6 mice in several behavioral tests. This
recovery parallels the enhanced regeneration of CST axons in
MRL/MpJ mice. Our data suggest that these axons have a
facilitated passage across the injury site because of the reduced
astrocytic response and diminished micro-cavity formation in
MRL/MpJ mice. The reduced astrocytic response is probably due
to reduced cell proliferation post-injury and reduced astrocytic
differentiation of the proliferating cells. In addition, we observed
an increased microglial differentiation in MRL/MpJ mice,
suggesting a possible role of the inflammatory response in the
MRL/MpJ spinal cord repair mechanisms. Finally, to evaluate the
molecular basis of enhanced spinal cord repair, we examined the
gene expression changes after SCI in MRL/MpJ and C57BL/6
mice. The microarray data complement our histological findings
and unveil a transcriptional profile that reflects the more efficient
spinal cord repair in MRL/MpJ mice
Locomotor recovery and axonal regeneration
The dorsal hemisection destroys a portion of supraspinal input
to the lumbar spinal cord and produces major, but incomplete, loss
of hindlimb function. Moreover, there is a slight possibility for a
minority of CST fibers to not have been fully transected in our
model. The limited recovery of C57BL/6 animals in motor tasks
Figure 4. Higher cell proliferation in intact spinal cord but
lower increase in cell proliferation after SCI in MRL/MpJ mice.
a, b, Immunohistochemical staining for BrdU (arrowheads) on cross
sections at the mid-thoracic level of intact spinal cord in C57BL/6 (a)
and MRL/MpJ (b) mice 24 h after the last of 6 daily BrdU injections. c,
Graphs show the amount of BrdU-labeled nuclei per mm
3 in the intact
spinal cord at the thoracic level 24 h and 4 weeks after the last BrdU
injection. MRL/MpJ mice showed a 1.56higher level of cell proliferation
than C57BL/6. Cell survival was assessed at 4 weeks and there was no
significant difference between the two strains. d, Number of BrdU-
labeled nuclei per mm
3 in the injured spinal cord 1, 54 and 109 dpi.
BrdU was injected after injury and for the 6 following days. MRL/MpJ
spinal cord showed less cell proliferation at 1 and 54 dpi. e, f, Sagittal
sections of the lesion epicenter at 54 dpi stained for BrdU in C57BL/6 (e)
and MRL/MpJ (f) mice. Asterisks denote significant difference between
MRL/MpJ and C57BL/6, P,0.05 (Student’s t-test). Scale bar, 260 mm.
doi:10.1371/journal.pone.0030904.g004
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fibers. Recently, it has been demonstrated that local plasticity after
SCI creates new circuits between descending CST fibers and
cervico-lumbarpropriospinal neurons[37].InMRL/MpJ mice,the
recovery of locomotor function was significantly improved. Only in
the MRL/MpJ mice did we find CST fiber growth caudal to the
injury site, suggesting an important role for regrowing fibers in
behavioral recovery. CST axonal regeneration, similar to what we
observed in MRL/MpJ mice, has been associated with functional
recovery after treatment and in transgenic mice [8,38,39,40,41,42].
It is also possible that the inherent plasticity of the injured spinal
cord for creating new circuitries [37] is enhanced in MRL/MpJ
mice. We assume that MRL/MpJ CST axons grow because of a
more permissive environment at the injury site: (i) we observed
fewer micro-cavitiesprovidinga better environment for tissuerepair
and axonal regeneration [43,44] and (ii) we found fewer astrocytes
at the injury site, which have been shown to form a physical barrier
preventing axonal growth [7]. Thus, we suggest that MRL/MpJ
mice have a more permissive environment for axonal regeneration,
with a reduced physical barrier and probably a diminished
production of growth-inhibitory molecules.
Astrocytic response
For both MRL/MpJ and C57BL/6 mice, the majority of
proliferating cells at the injury site differentiated into astrocytes.
However, C57BL/6 mice had twice as many newborn astrocytes
than MRL/MpJ. Astrocytes are the major contributor to the
growth-inhibitory scar after an injury, which is one of the obstacles
for successful regeneration. It has been suggested that part of the
astrogliotic scar formed after injury is attributable to newly
generated astrocytes and not to activation or migration of resident
astrocytes [33]. MRL/MpJ injured spinal cord contains fewer
newborn astrocytes, probably due to (i) a diminished increase in
cell proliferation at the injury site and (ii) a lower astrocytic
differentiation of the proliferating cells. X-irradiation treatment
eliminates rapidly dividing cells after SCI, suppresses glial scar
formation [9,45] and improves functional recovery [9,46]. Taken
together, these data suggest that limiting cell proliferation upon
Figure 5. Reduced astrocytic differentiation in MRL/MpJ injured spinal cord. Sagittal sections of the lesion epicenter at 54 dpi (a–l) and
109 dpi (m–r) labeled for BrdU (green) and lineage markers (red): GFAP (a–f), NG2 (g–l), OX-42 (m–r) in C57BL/6 (a–c, g–i, m–o) and MRL/MpJ (d–f,
j–l, p–r) mice. Higher magnifications of cells marked by the arrowheads are shown in boxed inserts. s–v, Graphs represent the quantification of BrdU-
labeled cells stained for a specific marker at 54 dpi (s, u) and 109 dpi (t, v) shown as percentage of all BrdU-labeled cells (s, t) and as absolute number
of co-stained BrdU-labeled nuclei per mm
3 (u, v). At 54 dpi, C57BL/6 mice showed more NG2/BrdU- and GFAP/BrdU-positive cells than MRL/MpJ
mice. At 109 dpi, C57BL/6 mice had still more GFAP/BrdU-expressing cells than MRL/MpJ mice; however, OX-42/BrdU-positive cells were only found
in MRL/MpJ spinal cord (2.760.9%). Asterisks denote significant difference between MRL/MpJ and C57BL/6, P,0.05 (Student’s t-test). Scale bar,
100 mm( a–i); 50 mm( p–r); 50 mm for boxed area (a–i); 25 mm for boxed area (p–r).
doi:10.1371/journal.pone.0030904.g005
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of scar tissue.
Inflammatory response
Our data from the gene profiling analysis at 4 dpi suggest an
amplified inflammatory response in injured MRL/MpJ spinal
cord. Among the genes exclusively differentially expressed in
MRL/MpJ injured spinal cord, the second highest fold change
difference (x7.59) is the allograft inflammatory factor 1 gene (Aif1;
Table 1). This gene encodes an interferon (IFN)-gamma-inducible
Ca2+-binding EF-hand protein. In the brain, a subset of microglial
cells constitutively expresses AIF-1 [47]. Increased numbers of
AIF-1-immunoreactive macrophages/microglial cells were ob-
served in brain tumors and ischemia [48] as well as after SCI [49].
The spinal cord tissue analysis at 109 dpi showed a higher rate
of microglia differentiation and/or macrophage recruitment in
MRL/MpJ mice, indicating that the immune response might be
sustained for the entire repair process. Immune system activity has
traditionally been considered harmful for recovery after SCI
[48,50,51,52]. However, some studies have shown the potential
beneficial effect of a strong inflammatory response. For example,
Franzen and colleagues [53] have transplanted macrophages into
the injured adult rat spinal cord and suggest that macrophages
may exert beneficial effects by degrading myelin products, which
Figure 6. Gene expression profiling of the MRL/MpJ and C57BL/6 injured spinal cord. a, Using loose criteria (dChip1.3 fold change.1.2
OR Drop method confidence=50%), 1538 genes were found to be differentially expressed in C57BL/6 spinal cord 4 days after hemisection. Using
strict criteria (dChip1.3 fold change.1.2 AND Drop method confidence=95%), 745 differentially expressed genes were found in MRL/MpJ spinal cord
4 days after hemisection, and 272 of these genes were exclusive for the MRL/MpJ injured spinal cord. b, Classification by biological function of genes
up-regulated exclusively in MRL/MpJ injured spinal cord. c, Classification by biological function of genes down-regulated exclusively in MRL/MpJ
injured spinal cord.
doi:10.1371/journal.pone.0030904.g006
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extracellular matrix. Moreover, Rapalino and colleagues [54]
observed partial recovery of paraplegic rats after implantation of
stimulated homologous macrophages. Lastly, Foote and Blake-
more [55] have shown that inflammation stimulates remyelination
in areas of chronic demyelination. The increased immune
response seen in the gene profiling analysis might be due to a
more permeable blood-brain-barrier (BBB) because of reduced
gliosis. Furthermore, MRL/MpJ mice contain elevated numbers
of macrophage progenitor cells circulating in their blood [56],
which could possibly pass the more permeable BBB, invade the
injury site and proliferate.
Interestingly the Transforming Growth Factor beta is a key
regulator in immune responses [57] and its mRNA is upregulated
1.9-fold more in MRL/MpJ injured spinal cord. Injecting TGFb1
was shown to stimulate astrocytes [58]; however, a recent study
found an exacerbated astroglial reaction in TGFb12/2 mice
[59]. The spinally injured MRL/MpJ mice in our studies showed
a reduced astroglial reaction and decreased micro-cavity forma-
tion. Importantly, TGFb1 was shown to promote the survival of
various CNS neurons in vitro, including motoneurons [60].
Additionally, TGFb1 prevents neuronal degeneration caused by
hypoxic or excitotoxic injury in vitro and rescues hippocampal CA1
neurons from death after transient ischemia in vivo [61,62].
Furthermore, anti-TGFb1 treatment following SCI exacerbates
secondary damage by increasing the size of cavities in the injured
tissue [63], and treatment of SCI rats with TGFb1 reduces lesion
volume [64].
The inbred MRL/MpJ strain has a mild autoimmune disorder
and is used as a background strain for mutating the Fas gene
leading to lupus erythematosus (SLE). The severity of autoimmu-
nity in these mutant mice is strongly affected by the genetic
background in which they are placed [65]. The inbred MRL/MpJ
strain background creates a severe lupus disease, and even Fas-
sufficient MRL/MpJ mice suffer from a mild-late-onset SLE [66].
Interestingly, recent evidence suggests that autoimmunity is an
endogenous response to CNS injury and that it can be beneficial
for repair [67,68]. Further studies showed that passive transfer of
T-cells specific to myelin basic protein reduces neuronal loss after
SCI and promotes recovery in rats [69,70,71]. Together these data
suggest that part of MRL/MpJ functional recovery might be
linked to their mild autoimmune disorder.
Brain repair versus spinal cord repair
Hampton and colleagues [72] studied the brain response to
injury in MRL/MpJ mice. They did not observe enhanced axonal
regeneration after cutting the dopaminergic projection from the
substantia nigra to the striatum. Neither did they see a reduced
scar after a stab lesion to the cortex. The only common
observation between this and the present study was the enhanced
and prolonged microglial activity.
In contrast to what we found in the spinal cord, they observed a
higher increase in cell proliferation in the cortex after injury.
Interestingly, in MRL/MpJ spinal cord we found a dramatic
+35.88-fold change for a gene whose over-expression in
mammalian cells inhibits cell proliferation: the interferon activated
gene 202B (Ifi202b) encoding the p202b protein. This inhibition of
proliferation might be correlated with the binding and inhibition
of the activity of several transcription factors by p202, such as c-
Fos, c-Jun, AP2, E2F-1, E2F-4, MyoD, myogenin, and NF-kB p50
and p65 [73,74,75].
In unlesioned MRL/MPJ mice, we observed a lower cell
proliferation in the hippocampus than in C57BL/6 animals [76],
whereas in the uninjured MRL/MpJ spinal cord we observed a
higher cell proliferation. Proliferation in the brain and the spinal
cord are differently regulated in intact tissue, therefore it might be
also the case following injury. In general, spinal cord and brain
seem to react conversely regarding cell proliferation: running
increases cell proliferation in the hippocampus but decreases
proliferation in the spinal cord of C57BL/6 (our unpublished
data).
Another disparity between brain and spinal cord involves the
inflammatory response. The acute inflammatory response to
traumatic injury is significantly greater in the spinal cord than in
the cerebral cortex [77]. Overall, we suspect that the disparity
between MRL/MpJ brain and spinal cord repair might be due to
a combination of intrinsic differences in cell proliferation and
inflammatory response.
Hemisection versus Contusion
More recently, Kostyk and colleagues [78] have assessed the
spinal cord regenerative abilities at T9 of MRL/MpJ versus C57/
Bl6 mice. They also reported a robust axon growth within the
lesion at 28 dpi in MRL/MpJ mice. However, the extent of
locomotor recovery was reported to be impaired in the MRL/MpJ
mice by 42 dpi. They further described evidence of ongoing
degeneration both within and around the lesion site at 42 dpi.
Interestingly, Kostyk and colleagues have used a contusion model
using rapid displacement of an impounder on the exposed spinal
cord following a dorsal laminectomy producing a contusion of
moderate severity. These data are consistent with our initial pilot
contusion data using the IH-impactor device at 50Kdynes (data
not shown), which lead to impaired locomotor recovery in MRL/
MpJ mice by 43 dpi. This is in contrast to the present study using a
dorsal hemisection model where axonal growth was consistent
with functional recovery. It is important to highlight that to inflict
a contusion injury using an impounder, it is necessary to make a
very large laminectomy. This is in contrast with making a very
small laminectomy for a dorsal hemisection. Interestingly,
postmortem dissection of our contused mouse samples (data not
shown) uncovered a cartilaginous overgrowth within the large
laminectomy region inducing a fusion between the remaining
neighboring vertebrae leading to extreme spinal column distor-
tion. This distortion possibly explains the poor motor performance
of this contusion group. In contrast, such cartilaginous overgrowth
was never observed with small laminectomies associated with the
dorsal hemisection procedures.
Moreover, a contusion injury is a crude injury as opposed to a
micro-scissors hemisection, which is a sharp injury. Interestingly, it
has been shown that regeneration of the ear in MRL/MpJ mice
depends on the type of wound trauma, where a crude injury
(punch) does not heal as well as a sharp injury (clinical biopsy)
[79]. Indeed, Rajnoch and colleagues [79] have previously shown
that in crude thumb-punched MRL/MpJ ears, an increase in
wound area diameter was still observed at the day-28 time point.
By contrast, biopsy-punched MRL/MpJ ears showed an 85%
wound closure over the same period.
The observations of this study, together with Hampton and
colleagues [72] as well as Kostyk and colleagues [78] findings
suggest that the occurrence of an enhanced regenerative ability is
not exclusively dictated by genetic influences, but is also highly
dependent on local cellular interactions and injury type.
Validation of the gene expression profiling after SCI
To help us understand the events occurring in the MRL/MpJ
spinal cord after injury, we analyzed gene expression changes after
SCI in both strains and compared the results to compile a list of
genes differentially expressed exclusively in MRL/MpJ injured
Recovery from SCI in MRL/MpJ Mice
PLoS ONE | www.plosone.org 12 February 2012 | Volume 7 | Issue 2 | e30904spinal cord. Since it is known that genes are differentially regulated
in different strains of mice or rats [80,81], we only focused on
genes that are specifically expressed in injured MRL/MpJ spinal
cord. We have evidences that the MRL/MpJ differentially
expressed genes identified in this screen are potentially implicated
in spinal cord repair. First, we observed, in both strains some genes
that have previously been shown to be differentially regulated after
SCI. For example, both mouse strains show expression changes in
genes coding for proteins that influence apoptosis: Caspase 3 is
upregulated and Caspase 7 is downregulated, as observed
previously [25,82]. These studies also found Bax and Bak1 to be
upregulated upon SCI, as we have in the present study. For both
injured strains, genes coding for cathepsin proteases are upregu-
lated (cathepsins B, C, D, L and S), as previously reported
[25,83,84,85]. These data validate that our method is useful for
identifying candidate genes that contribute to differences in spinal
cord repair between MRL/MpJ and C57BL/6 mice. Second, we
found that some of the genes differentially expressed in MRL/MpJ
injured spinal cord are located on the quantitative trait loci QTLs
that control ear healing in MRL/MpJ mice [16,19,21]. These
studies found linkage on chromosome 7. Interestingly, some of the
genes differentially expressed in injured MRL/MpJ spinal cord
(e.g., genes coding for the mitochondrial uncoupling protein 2 and
TGFb1) are located in or near the loci on chromosome 7.
Additionally, Masinde et al. [21] found linkage on chromosome 1,
where Ifi202b, another of our candidate genes, is located. We
found that some genes differentially expressed in the MRL/MpJ
healing ear are also present on our gene list. For example we
observed that Decorin is less up-regulated whereas DEAD/H and
Proteasome (prosome, macropain) are more up-regulated in MRL/MpJ,
as previously reported in a different lesion model [21]. We also
found that integrin beta2 and secretory granule proteoglycan are more up-
regulated in MRL/MpJ upon injury, as shown previously [20].
Since rapid wound healing in MRL/MpJ mice is a genetically
controlled quantitative trait [15,19], we expected that the soft
tissue regeneration QTLs and genes found in studies on ear
regeneration in MRL/MpJ mice would overlap with the genes
discovered in this study. The fact that some of the differentially
expressed genes are located within the QTL regions or have
already been identified provides another validation of our screen.
Third, our microarray data complement our histological findings.
Indeed, the general tendency is the up-regulation of genes involved
in repair mechanisms. Moreover, genes involved in lowering cell
proliferation (e.g., Ifi202b) and increasing the immune response
(e.g., Aif-1) are up-regulated in the injured MRL/MpJ spinal cord.
We recognize that this study may underestimate the number of
genes involved in MRL/MpJ spinal cord healing because (i) we
examined only one time point and some changes in the expression
may occur at an earlier or later stage of the repair process, (ii) we
used only one strain of mice for control, and (iii) we collected only
the lesion epicenter and additional genes might be differently
regulated rostral and/or caudal to the lesion. Moreover, it would
be interesting in future studies to extract RNA from specific cell
types to identify the particular cells responsible for these significant
gene expression changes. However, the genes identified here may
play a role in the repair processes following SCI and further
characterization of these candidates might elucidate some
molecular mechanisms of spinal cord repair.
Conclusion and perspectives
This study shows that the MRL/MpJ mice are able to recover
faster and better after spinal cord dorsal hemisection than C57BL/
6 mice. Our data suggest that a sustained immune response and
decreased astrocytic activity are likely to be part of a complex
recovery course. Although our data are not able to explain the
detailed mechanisms of such a recovery, they do demonstrate that
the repair process after SCI is multifaceted. Many pathways are
involved, all of which need to be considered and each of which
needs to work at an optimal ‘‘level’’ to result in behavioral
recovery.
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